← All trials
NCT03182816
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 7, 2017
- Primary completion
- Jan 20, 2019
- Completion date
- Apr 20, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 40
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Shanghai Cell Therapy Research InstituteLead sponsor
- Shanghai Cell Therapy Research InstituteStudy director
- Ningbo No. 5 HospitalOverall official - principal investigator
- Shanghai Cell Therapy Research InstituteStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.